Delivery Order SPE2DB22D2211-SPE2DB25FSDAP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 units under a firm fixed-price contract valued at $7,296.70. The award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,474.63 to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of June 17, 2025, and represents a non-competitive set-aside delivery against a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $1,125.60. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a ceiling value of $28,380.00. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $3,329.26. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-competitive set-aside contract. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $13,026.80. This competitively awarded, firm fixed-price contract was executed on September 2, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Modafinil 100 mg tablets in 30-count packages with a contract value of $1,923.92. This firm fixed-price delivery order, which is due for completion by July 15, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with the agency. The award was competitively procured with no set-aside designation and will be performed at the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in a 30-count configuration. This competitively awarded, firm fixed-price delivery order, issued on September 9, 2025, carries a ceiling value of $4,308.84 and is scheduled for completion by September 10, 2025. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a ceiling value of $4,621.97 and firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $3,468.69. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which is also designated as the...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDAPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Modafinil 100 mg tablets in a 30-count package. This firm fixed-price delivery order, valued at $3,471.88, was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025. The contract was competitively awarded with no set-aside designation and represents a routine pharmaceutical procurement supporting the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide. The parent contract facilitates efficient procurement for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with the DLA planning future regional Pharmaceutical Prime Vendor Global Program Generation V contracts to be awarded to multiple contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/18/25 |